Journal
BLOOD
Volume 140, Issue 18, Pages 1937-1950Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2022015451
Keywords
-
Categories
Funding
- Ministry of Education, Culture, Sports, and Science of Japan [KAKENHI: JP21K16239, JP22K19451, JP21H02945, JP19H03683]
- AMED [JP21cm0106585, JP20ck0106544, JP21ck0106644, JP21cm 0106505]
- Nippon Shinyaku Research Grant
- MSD Life Science Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Cell Science Research Foundation
- Princess Takamatsu Cancer Research Fund
- Naito Foundation
- Kobayashi Foundation for Cancer Research
- Japan Agency to Medical Research and Development (AMED) [JP21am0101103]
Ask authors/readers for more resources
This study investigates the mechanism by which TET2-mutant immune cells enable the development of Angioimmunoblastic T-cell lymphoma (AITL). The results reveal that Tet2-deficient immune cells play a crucial role in AITL development, and aberrant GCB cells in AITL undergo clonal evolution with recurrent mutations in genes related to core histones. Cd40-Cd40lg is identified as a possible mediator of interactions between GCB and tumor cell clusters.
Angioimmunoblastic T-cell lymphoma (AITL) is proposed to be initiated by age-related clonal hematopoiesis (ACH) with TET2 mutations, whereas the G17V RHOA mutation in immature cells with TET2 mutations promotes the development of T follicular helper (TFH)-like tumor cells. Here, we investigated the mechanism by which TET2-mutant immune cells enable AITL development using mouse models and human samples. Among the 2 mouse models, mice lacking Tet2 in all the blood cells (Mx-Cre x Tet2(flox/flox) x G17V RHOA transgenic mice) spontaneously developed AITL for approximately up to a year, while mice lacking Tet2 only in the T cells (Cd4-Cre x Tet2(flox/flox) x G17V RHOA transgenic mice) did not. Therefore, Tet2-deficient immune cells function as a niche for AITL development. Single-cell RNA-sequencing (scRNA-seq) of >50 000 cells from mouse and human AITL samples revealed significant expansion of aberrant B cells, exhibiting properties of acti-vating light zone (LZ)-like and proliferative dark zone (DZ)-like germinal center B (GCB) cells. The GCB cells in AITL clonally evolved with recurrent mutations in genes related to core histones. In silico network analysis using scRNA-seq data identified Cd40-Cd40lg as a possible mediator of GCB and tumor cell cluster interactions. Treatment of AITL model mice with anti-Cd40lg inhib-itory antibody prolonged survival. The genes expressed in aberrantly expanded GCB cells in murine tumors were also broadly expressed in the B-lineage cells of TET2-mutant human AITL. Therefore, ACH-derived GCB cells could undergo independent clonal evolution and support the tumorigenesis in AITL via the CD40-CD40LG axis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available